Labcorp to Speak at the 44th Annual J.P. Morgan Healthcare Conference
Labcorp (NYSE: LH) will participate in a fireside chat at the 44th Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Labcorp (NYSE: LH) will participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 13, 2026 at 4:30 p.m. PT. A live audio webcast will be available on the company investor relations site ir.Labcorp.com and will be archived for replay.
The presentation offers investors and analysts direct access to management commentary on strategy and market outlook; no financial results or guidance are included in this announcement.
Details
News Market Reaction – LH
On Dec 31, the first trading day after this news, LH closed 0.87% below the previous close.
Data tracked by StockTitan Argus for the Dec 31 session.
Key Figures
- Conference edition
- 44th Annual
- J.P. Morgan Healthcare Conference appearance
- Conference date
- Jan. 13
- Fireside chat scheduled at J.P. Morgan Healthcare Conference
- Session time
- 4:30 p.m. PT
- Timing of Labcorp fireside chat
- Revenue
- $3.56B
- Q3 2025 results
- Revenue growth
- 8.6%
- Q3 2025 year-over-year growth
- Diluted EPS
- $3.12
- Q3 2025 vs $2.00 prior year
- Adjusted EPS
- $4.18
- Q3 2025, up 19.4% YoY
- Operating margin
- 11.1%
- Q3 2025 operating income margin
Historical Context
-
Completed $194M cash acquisition of CHS outreach lab assets across 13 states.
-
Appointed Novartis U.S. leader Victor Bulto to Labcorp’s Board of Directors.
-
Published MRD Plasma Detect studies in Nature Medicine and Clinical Cancer Research.
-
Reported Q3 2025 revenue and EPS growth with updated full-year guidance and cash flow.
-
Announced nationwide offering of Roche’s FDA-cleared Elecsys pTau181 Alzheimer’s test.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURLINGTON, N.C., Dec. 30, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that the company will participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 13, at 4:30 p.m. PT.
A live audio webcast of the fireside chat will be available via the Company Investor Relations website at ir.Labcorp.com and archived for replay.
About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 70,000 employees serve clients in approximately 100 countries, provided support for more than
View original content to download multimedia:https://www.prnewswire.com/news-releases/labcorp-to-speak-at-the-44th-annual-jp-morgan-healthcare-conference-302650873.html
SOURCE Labcorp Holdings Inc
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.